Search Results 431-440 of 17116 for nivolumab

  1. Clinical Trials - ICI And Response In Autoimmunity

    ... nivolumab, cemiplimab, atezolimumab, durvalumab, or avelumab. Presence of inflammatory arthritis defined by: Provider documents inflammatory arthritis in one ...

  2. FOG-001 In Locally Advanced Or Metastatic Solid Tumors - Mayo Clinic

    ... Nivolumab * Non-MSI-H or non-dMMR (by local testing) CRC with or without liver metastases. * MSI-H CRC or solid tumors that are WPAM and resistant to a-PD-1 ...

  3. Early Identification Of Chemotherapy Induced Cardiac Toxicity - Mayo Clinic

    Immune checkpoint inhibitors (Ipilimumab, Nivolumab, Pembrolizumab). Exclusion Criteria: Coronary artery disease. Significant (more than mild) valvular ...

  4. Gastroenterology and Hepatology - Clinical trials

    In-home Versus In-Clinic Subcutaneous Nivolumab Administration Through Connected And Remote Cancer CARE Beyond Walls. Jacksonville, Fla. The purpose of this ...

  5. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma - Mayo Clinic

    the combination regimen of nivolumab + ipilimumab. Exposure to a prior treatment regimen for ≥4 weeks is considered a prior line of therapy, regardless of ...

  6. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

    About this study. The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks ...

  7. Mayo Clinic Q and A: Treatment for liver cancer

    The U.S. Food and Drug Administration recently approved a form of immunotherapy with a drug called nivolumab for liver cancer. Immunotherapy works by ...

  8. Nipocalimab-aahu (intravenous route) - Mayo Clinic

    Nipocalimab-aahu injection is used to treat a nerve and muscle disease called generalized myasthenia gravis (gMG) in patients who are anti-acetylcholine ...

  9. A Study Using Docetaxel with or without MLN1117 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer - Mayo Clinic

    ... nivolumab or other immune-checkpoint inhibitors but progressed on or after the therapy. For Phase 1b of the study. Participants who have experienced failure ...

  10. Endometrial Cancer Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine how well cabozantinib and nivolumab work in treating patients with endometrial cancer that has come back or spread to ...